NCT07293611

Brief Summary

A Study at Multiple Centers to Evaluate the Safety and Practicality of the Levita Magnetic Surgical System for Use in Laparoscopic Upper Gastrointestinal Surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

March 30, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 12, 2026

Completed
Last Updated

July 13, 2026

Status Verified

July 1, 2026

Enrollment Period

1 month

First QC Date

December 12, 2025

Last Update Submit

July 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of Participants with Device and/or Procedure Related Adverse Events

    Adverse events will be summarized by relatedness to the device and/or procedure, seriousness and level of severity.

    From enrollment to end of follow up at 30 days.

  • Average Number of Ports

    Ability to adequately retract the stomach, omentum, and small bowel to achieve effective exposure of the target tissue. Adequate retraction will be deemed to be achieved if an additional port that is typically used for retraction and exposure of target tissues can be eliminated.

    During index procedure.

Study Arms (1)

Magnetic Surgical System in laparoscopic upper gastrointestinal procedures

EXPERIMENTAL
Device: Levita Magnetic Surgical System

Interventions

The Magnetic Surgical System (MSS), which was cleared for market in the U.S. most recently per 510(k) K252435 and is commercially available in Chile, is composed of two hand-held instruments: a Magnetic Grasper and an external Magnetic Controller. The Magnetic Grasper is comprised of two main components: a detachable Grasper Tip and a Shaft. The detachable Grasper Tip provided with the Magnetic Grasper is 6.5cm in length. An optional 12.5cm length detachable Grasper Tip may be used as a replacement for the 6.5cm Grasper Tip and can be used with the Shaft interchangeably. The Magnetic Controller is a single unit with handles that is held external to the body and emits a magnetic field that attracts the detachable Grasper Tip. In this study the 6.5 Grasper Tip will be used.

Magnetic Surgical System in laparoscopic upper gastrointestinal procedures

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI range of 20 to 60kg/m2
  • Scheduled to undergo laparoscopic procedures
  • Willing and able to provide a written Informed Consent Form (ICF) to participate in the study prior to any study- required procedures

You may not qualify if:

  • Individuals with pacemakers, defibrillators, or other electromedical implants
  • Individuals with ferromagnetic implants
  • American Society of Anesthesiologists (ASA) score of III or IV
  • Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure)
  • Clinical history of impaired coagulation confirmed by abnormal blood tests
  • Individuals who have signs of hepatic abnormality (e.g.: cirrhosis, liver failure, increase in liver enzymes, etc.)
  • Anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use
  • Pregnant or wishes to become pregnant during the length of study participation
  • Individual is not likely to comply with the follow-up evaluation schedule
  • Participating in a clinical trial of another investigational drug or device
  • Prisoner or under incarceration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinica Colonial

Huechuraba, Santiago Metropolitan, 8580645, Chile

Location

Hospital Luis Tisne

Peñalolén, Santiago Metropolitan, 7930124, Chile

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2025

First Posted

December 19, 2025

Study Start

March 30, 2026

Primary Completion

May 5, 2026

Study Completion

June 12, 2026

Last Updated

July 13, 2026

Record last verified: 2026-07

Locations